JP2023505271A5 - - Google Patents
Info
- Publication number
- JP2023505271A5 JP2023505271A5 JP2022533615A JP2022533615A JP2023505271A5 JP 2023505271 A5 JP2023505271 A5 JP 2023505271A5 JP 2022533615 A JP2022533615 A JP 2022533615A JP 2022533615 A JP2022533615 A JP 2022533615A JP 2023505271 A5 JP2023505271 A5 JP 2023505271A5
- Authority
- JP
- Japan
- Prior art keywords
- retromercore
- composition
- protein
- vps26b
- vps26a
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025125690A JP2025149978A (ja) | 2019-12-05 | 2025-07-28 | アルツハイマー病および他の神経変性障害の処置のためのレトロマーの安定化 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962943999P | 2019-12-05 | 2019-12-05 | |
| US62/943,999 | 2019-12-05 | ||
| US202063074578P | 2020-09-04 | 2020-09-04 | |
| US63/074,578 | 2020-09-04 | ||
| PCT/US2020/063627 WO2021113824A1 (en) | 2019-12-05 | 2020-12-07 | Stabilization of retromer for the treatment of alzheimer's disease and other neurodegenerative disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025125690A Division JP2025149978A (ja) | 2019-12-05 | 2025-07-28 | アルツハイマー病および他の神経変性障害の処置のためのレトロマーの安定化 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023505271A JP2023505271A (ja) | 2023-02-08 |
| JP2023505271A5 true JP2023505271A5 (https=) | 2023-12-14 |
Family
ID=76222705
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022533615A Withdrawn JP2023505271A (ja) | 2019-12-05 | 2020-12-07 | アルツハイマー病および他の神経変性障害の処置のためのレトロマーの安定化 |
| JP2025125690A Pending JP2025149978A (ja) | 2019-12-05 | 2025-07-28 | アルツハイマー病および他の神経変性障害の処置のためのレトロマーの安定化 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025125690A Pending JP2025149978A (ja) | 2019-12-05 | 2025-07-28 | アルツハイマー病および他の神経変性障害の処置のためのレトロマーの安定化 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230021959A1 (https=) |
| EP (1) | EP4069315A4 (https=) |
| JP (2) | JP2023505271A (https=) |
| KR (1) | KR20220152192A (https=) |
| CN (2) | CN115297891A (https=) |
| AU (1) | AU2020395327A1 (https=) |
| BR (1) | BR112022011073A2 (https=) |
| CA (1) | CA3160785A1 (https=) |
| IL (1) | IL293599A (https=) |
| MX (1) | MX2022006895A (https=) |
| PH (1) | PH12022551373A1 (https=) |
| WO (1) | WO2021113824A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023159238A1 (en) * | 2022-02-21 | 2023-08-24 | The Scripps Research Institute | Mef2 transcriptional activators to treat neurologic conditions |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1938104A2 (en) * | 2005-10-17 | 2008-07-02 | Institute for Systems Biology | Tissue-and serum-derived glycoproteins and methods of their use |
| US20080214482A1 (en) * | 2005-11-15 | 2008-09-04 | Scott Small | Retromer-based assays and methods for treating alzheimer's disease |
| WO2009108274A2 (en) * | 2008-02-26 | 2009-09-03 | The University Of North Carolina At Chapel Hill | Methods and compositions for adeno-associated virus (aav) with hi loop mutations |
| EP2607900A1 (de) * | 2011-12-22 | 2013-06-26 | Protagen AG | Markersequenzen für Brustkrebs und deren Verwendung |
| MX367100B (es) * | 2012-02-17 | 2019-08-05 | The Children´S Hospital Of Philadelphia | Composiciones del vector aav y metodos para su transferencia genetica a celulas, organos y tejidos. |
| WO2014110481A2 (en) * | 2013-01-11 | 2014-07-17 | The Trustees Of Columbia University In The City Of New York | Rab7l1 interacts with lrrk2 to modify intraneuronal protein sorting and parkinson' s disease risk |
| US20160250182A1 (en) * | 2013-01-11 | 2016-09-01 | The Trustees Of Columbia University In The City Of | Rab7l1 interacts with lrrk2 to modify intraneuronal protein sorting and parkinson's disease risk |
| GB201409519D0 (en) * | 2014-05-29 | 2014-07-16 | Univ Leicester | Senescent cell biomarkers |
| AU2016324317A1 (en) * | 2015-09-17 | 2018-03-08 | Coda Biotherapeutics, Inc. | Compositions and methods for treating neurological disorders |
| WO2017191274A2 (en) * | 2016-05-04 | 2017-11-09 | Curevac Ag | Rna encoding a therapeutic protein |
| WO2018112446A2 (en) * | 2016-12-18 | 2018-06-21 | Selonterra, Inc. | Use of apoe4 motif-mediated genes for diagnosis and treatment of alzheimer's disease |
| BR112020006661A2 (pt) * | 2017-10-03 | 2020-10-13 | Prevail Therapeutics, Inc. | terapias de genes para distúrbios lipossomais |
| US20190345516A1 (en) * | 2018-03-12 | 2019-11-14 | Musc Foundation For Research Development | Methods for treating eye disease |
-
2020
- 2020-12-07 AU AU2020395327A patent/AU2020395327A1/en active Pending
- 2020-12-07 PH PH1/2022/551373A patent/PH12022551373A1/en unknown
- 2020-12-07 CN CN202080093935.2A patent/CN115297891A/zh active Pending
- 2020-12-07 WO PCT/US2020/063627 patent/WO2021113824A1/en not_active Ceased
- 2020-12-07 CA CA3160785A patent/CA3160785A1/en active Pending
- 2020-12-07 MX MX2022006895A patent/MX2022006895A/es unknown
- 2020-12-07 IL IL293599A patent/IL293599A/en unknown
- 2020-12-07 JP JP2022533615A patent/JP2023505271A/ja not_active Withdrawn
- 2020-12-07 EP EP20896932.9A patent/EP4069315A4/en active Pending
- 2020-12-07 CN CN202510180683.1A patent/CN120114618A/zh active Pending
- 2020-12-07 US US17/782,357 patent/US20230021959A1/en active Pending
- 2020-12-07 BR BR112022011073A patent/BR112022011073A2/pt unknown
- 2020-12-07 KR KR1020227022902A patent/KR20220152192A/ko active Pending
-
2025
- 2025-07-28 JP JP2025125690A patent/JP2025149978A/ja active Pending